Toward understanding the pathogenesis of craniosynostosis through clinical and molecular correlates

Clinical Genetics

Volumn 53, Issue 2, 1998, Pages 79-86

  Jabs, Ethylin Wang ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Apert; BARX2; Beare stevenson; Craniosynostosis; Craniosynostosis Boston type and Jacobsen syndromes; Crouzon pfeiffer; Fibroblast growth factor receptor; Jackson weiss; MSX2; Saethre chotzen; TWIST

Indexed keywords

CRANIOFACIAL SYNOSTOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031956847     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb02648.x     Document Type: Review

References (42)

1. Cohen MM Jr. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Raven Press, 1986: 413-590.
2. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz De Luna RI, Delgado CG, Gonzalez-Ramos M, Jabs EW. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997: 15: 36-41.
3. El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin A-L, Munnich A, Bonaventure J. Mutations of the TWIST gene in Saethre-Chotzen syndrome. Nat Genet 1997: 15: 42-46.
4. Gorlin RJ, Cohen MM Jr, Levin LS. Syndromes of the Head and Neck, 3rd edn. New York: Oxford University Press, 1990: 519-539.
5. Saethre M. Ein beitrag zum turmschadelproblem (Pathogenese, erblichkeit und symptomatologie). Dtsch Z Nervenheikd 1931: 119: 533-555.
6. Chotzen F. Eine eigenartige familiare Entwicklungsstorung (Akrocephalosyndaktylie, dysostosis craniofacialis und hypertelorismus). Monatsschr Kinderheilkd 1932: 55: 97-122.
7. Stoetzel C, Weber B, Bourgeois P, Bolcato-Bellemin AL, Perrin-Schmitt F. Dorso-ventral and rostro-caudal sequential expression of M-twist in the post-implantation murine embryo. Mech Dev 1995: 51: 251-263.
8. Fuchtbauer EM. Expression of M-Twist during post-implantation development of the mouse. Dev Dynam 1995: 204: 316-322.
9. Murray SS, Glackin CA, Winters KA, Gazit D, Kahn AJ, Murray EJ. Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J Bone Miner Res 1992: 7 (10): 1132-1138.
10. Krebs I, Weis I, Hudler M, Rommens JM, Roth H, Scherer SW, Tsui L-C, Fuchtbauer E-M, Grzeschik K-H, Tsuji K, Kunz J. Translocation breakpoint maps 5 kb 3′ from TWIST in a patient affected with Saethre-Chotzen syndrome. Hum Mol Genet 1997: 6 (7): 1079-1086.
11. Rose CSP, Patel P, Reardon W, Malcolm S, Winter RM. The TWIST gene, although not disrupted in Saethre-Chotzen syndrome patients with apparently balanced translocations of 7p21, is mutated in familial and sporadic cases. Hum Mol Genet 1997: 6 (8): 1369-1373.
12. Lewanda AF, Green ED, Weissenbach J, Jerald H, Taylor E, Summar ML, Phillips JA III, Cohen M, Feingold M, Mouradian W, Clarren SK, Jabs EW. Evidence that the Saethre-Chotzen syndrome locus lies between D7S664 and D7S507, by genetic analysis and detection of a microdeletion in a patient. Am J Hum Genet 1994: 55: 1195-1201.
13. Engelkamp D, Van Heyningen V. Transcription factors in disease. Curr Opin Genet Dev 1996: 6: 334-342.
14. Vortkamp A, Gessler M, Le Paslier D, Elaswarapu R, Smith S, Grzeschik K-H. Isolation of a yeast artificial chromosome contig spanning the Greig cephalopolysyndactyly syndrome (GCPS) gene region. Genomics 1994: 22: 563-568.
15. de Kok YJM, van der Maarel SM, Bitner-Glindzicz M, Huber I, Monaco AP, Malcolm S, Pembry ME, Ropers HH. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 1995: 267: 685-688.
16. Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, Siegel-Bartelt J, Bierke-Nelson D, Bitoun P, Zabel BU, Carey JC, Murray JC. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996: 14: 392-399.
17. Park W-J, Bellus GA, Jabs EW. Mutations in fibroblast growth factor receptors: phenotypic consequences during eukaryotic development. Am J Hum Genet 1995: 57: 748-754.
18. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995: 11: 462-464.
19. Przylepa KA, Paznekas W, Zhang M, Golabi M, Bias W, Bamshad MJ, Carey JC, Hall BD, Stevenson R, Orlow SJ, Cohen MM Jr, Jabs EW. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat Genet 1996: 13: 492-494.
20. Wilkie AOM. Craniosynostosis: Genes and mechanisms. Hum Mol Genet 1997: 6 (10): 1647-1656.
21. Johnson DE, Williams LT. In: Vande Woude GF, Klein G, eds. Advances in Cancer Research, vol. 60. San Diego: Academic Press, 1993: 1-41.
22. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerisation, activation, and cell proliferation. Cell 1994: 79: 1015-1924.
23. Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA, Abrams LJ, Graham JM Jr, Feingold M, Moeschler JB, Rawnsley E, Scott AF, Jabs EW. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 1996: 58: 491-498.
24. Jackson CE, Weiss L, Reynold WA, Forman TF, Peterson JA. Craniosynostosis, midface hypoplasia and foot anomalies: an autosomal dominant phenotype in a large Amish kindred. J Pediatr 1976: 88: 963-968.
25. Jabs EW, Li X, Scott AF, Meyers GA, Chen W, Eccles M, Mao J-I, Charnas LR, Jackson CE, Jaye M. The Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994: 8: 275-279.
26. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridgc M, Slaney SF, Poole MD, Wilkie AOM. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 1995: 9: 173-176.
27. Lajeunie E, Ma HW, Bonaventure J, Munnich A, Le Merrer M. FGFR2 mutations in Pfeiffer syndrome. Nat Genet 1995: 9: 108.
28. Gorry MC, Preston RA, White GJ, Zhang Y, Singhal VK, Losken HW, Parker MG, Nwokoro NA, Post JC, Ehrlich GD. Crouzon syndrome: mutations in two spliceforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 1995: 4: 1387-1390.
29. Passos-Bueno MR, Sertie AL, Zatz M, Richieri-Costa A. Pfeiffer mutation in an Apert patient: how wide is the spectrum of variability due to mutations in the FGFR2 gene? Am J Med Genet 1997: 71: 243-245.
30. Shishido E, Higashijima S, Emori Y, Saigo K. Two FGF-receptor homologues of Drosophila: one expressed in mesodermal primordium in early embryos. Development 1993: 117: 751-761.
31. Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB, Snead ML, Maxson R. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993: 75: 443-450.
32. Lewanda AF, Morsey S, Reid CS, Jabs EW. Two craniosynostotic patients with 11q deletions, and review of 48 cases. Am J Med Genet 1995: 59: 193-198.
33. Penny LA, del Aquila M, Jones MC, Bergoffen JA, Cunniff C, Fryns JP, Grace E, Graham JM, Kousseff B, Mattina T, Syme J, Voullaire L, Zelante L, Zengerhaim J, Jones OW, Evans GA. Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet 1995: 56: 676-683.
34. Krasner A, Wallace L, Thiagalingam A, Jones C, Lengauer C, Diamond L, Kalikin L, Feinberg AP, Jabs EW, Tunnacliffe A, Baylin SB, Ball DW, Nelkin BD. The human BARX2 homeobox protein is a raS-responsive transcription factor and a candidate for involvement in Jacobsen syndrome (Submitted).
35. Reid CS, McMorrow LE, McDonald-McGinn DM, Grace KJ, Ramos FJ, Zackai EH, Cohen MM Jr, Jabs EW. Saethre-Chotzen syndrome with familial translocation at chromosome 7p22. Am J Med Genet 1993: 47: 637-639.
36. Lewanda AF, Meyers GA, Jabs EW. Craniosynostosis and skeletal dysplasias: fibroblast growth factor receptor defects. Proc Assoc Am Phys 1996: 108 (1): 19-24.
37. Muller U, Warman ML, Mulliken JB, Weber JL. Assignment of a gene locus involved in craniosynostosis 5qter. Hum Mol Genet 1993: 2 (2): 119-122.
38. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994: 8: 98-103.
39. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994: 8: 269-274.
40. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995: 9: 165-172.
41. Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 1995: 10: 357-359.
42. Pulleyn LJ, Reardon W, Wilkes D, Rutland P, Jones BM, Hayward R, Hall CM, Brueton L, Chun N, Lammer E, Malcolm S, Winter RM. Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locus. Eur J Hum Genet 1996: 4: 283-291.